Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Coronavirus: PM Modi...

    Coronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugs

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-23T14:31:24+05:30  |  Updated On 23 March 2020 9:01 AM GMT
    Coronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugs

    Delhi: With a view to ensure that there is no shortage of medicines in the country with the ongoing Corona crisis, the Prime Minister Shri Narendra Modi interacted with the leaders of the Pharma industry via video conferencing.

    Union Minister of State for Shipping, Chemicals, and Fertilizers, Principal Secretary, Cabinet Secretary, Secretaries of Health, Textiles, Department of Pharmaceuticals, Government of India and senior representatives from Pharmaceutical associations including Indian Pharmaceutical Alliance, Indian Drug Manufacturer Association, Organization of Pharmaceutical Producers of India, All India Organization of Chemists and Druggists, Torrent Pharmaceuticals, Bulk Drug Manufacturing Association and Association of Medical Device Industry participated in the interaction.erer

    Prime Minister said that pharma producers and distributors have a crucial role to play in combating the challenge of COVID-19. He said that not only does the industry need to ensure the maintenance of supply lines of essential medicines, medical kits, and equipment, but at the same time should try to come up with new and innovative solutions.

    He said that the government is committed to helping the industry in maintaining the supply of Active Pharmaceutical Ingredients (API), underlining the importance of the manufacture of such APIs within the country. He said that in order to ensure the production of critical drugs and medical equipment within the country, the government has approved schemes worth Rs 10,000 crore and Rs 4,000 crore respectively.

    Prime Minister requested the industry leaders to work on the manufacture of RNA Diagnostic Kits for COVID-19 on a war footing.

    He asked the medicine retailers and pharmacists to be on constant vigil to ensure that black marketing and hoarding of medicines is avoided and supply of essentials maintained. He suggested that wherever feasible, the supply of medicines in bulk may be avoided.

    Prime Minister said that in this hour of need, it is imperative for the industry to work continuously and also ensure that there is no shortage of workforce in the pharma sector. He suggested exploration of the home-delivery model to allow for maintenance of social distancing at pharmacies, and also promotion of usage of digital payment mechanisms to prevent the spread of the virus.

    The Pharmaceutical Associations thanked the Prime Minister for his leadership in this time of crisis. The Associations said that they are committed to maintaining the supply of essential medicines and equipment, and are also working on developing vaccines. They said that the government's policy announcements for the Pharma sector will give the sector a huge boost.

    Prime Minister appreciated the dedication and commitment of the industry and the zeal with which they are working. He said that due to the trust of people in them, they also have an important role to play in the dissemination of scientific information to the people.

    https://pubads.g.doubleclick.net/gampad/ads?iu=/21687779244/clinicalkey_video_ad&description_url=[placeholder]&tfcd=0&npa=0&sz=640x480&gdfp_req=1&output=vast&unviewed_position_start=1&env=vp&impl=s&correlator=

    Pharmaceuticals Secretary highlighted the tireless efforts of the government, working with airport and port authorities to ensure the supply of essentials. Health Secretary thanked the Pharmaceutical Associations and said that no shortage of supply has so far been detected, and also talked about the collaboration with Protective Wear Manufacturing Associations.

    Read also: Cabinet Nod To Rs 3000 Crore For 3 Bulk Drug Parks , Rs 6950 Crore Production Linked Incentive Scheme For Domestic Production Of APIs

    pm-modi essential-medicines rna-diagnostic-kit api coronavirus covid-19 

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X